Wall Street Zen Downgrades Pacific Biosciences of California (NASDAQ:PACB) to Sell

Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday. PACB has been the subject of several other research reports. Zacks Research downgraded shares of Pacific Biosciences of California from a [...]